Veronica Woodford
Women's Health · Bel Air, MDNPI 1720335441
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,037 of the $1,335 with a category attached, or 77.7%. 14 manufacturers reported payments, led by Astellas Pharma US Inc at 32.9% of the total.
Across 56 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$440
- Millicent US Inc$240
- Sage Therapeutics, LLC$115
- Sumitomo Pharma America, Inc.$71
- Coopersurgical, Inc.$71
- Hologic Sales And Service, LLC$67
- plus $331 from 8 others
What the payments were for
- Food & beverage$1,03778%
- Education$29722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 12 | $440 |
| Millicent US Inc | 15 | $240 |
| Sage Therapeutics, LLC | 4 | $115 |
| Sumitomo Pharma America, Inc. | 3 | $71 |
| Coopersurgical, Inc. | 4 | $71 |
| Hologic Sales And Service, LLC | 3 | $67 |
| Evofem Biosciences, Inc. | 3 | $66 |
| Myriad Women's Health, Inc. | 1 | $57 |
| Bayer | 3 | $55 |
| Vertex | 2 | $36 |
| Aspira Women's Health Inc | 2 | $33 |
| Pfizer | 2 | $31 |
| Organon | 1 | $27 |
| AbbVie | 1 | $27 |
How this compares
$1,335 in reported general payments places this provider in the 85th percentile of 95 women's health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 66 | $3,686 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 27 | $442 |
| Norethindrone | 12 | $285 |
Paid to pharmacies, not to this prescriber.
Other women's health in Bel Air
- Tiffany LopezBel Air$1K
- Christine DiblasiBel Air$334
- Carrie KirkpatrickBel Air$217
- Jasmine WhitcombBaltimore$15K
- Ariel PaskinBaltimore$5K
- Crystal SmithGambrills$4K
- Joyce HambaBethesda$3K
- Jamie HuppmannFulton$2K
- Aileen LardisAnnapolis$2K
- Brooke EllingerSilver Spring$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.